Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric

Milorad Tesic1,2, Branko Beleslin1,2, Vojislav Giga1,2

  • 1Clinic for CardiologyClinical Center of Serbia Belgrade Serbia.

Insights

Impaired coronary flow velocity reserve in the left anterior descending artery (CFVR LAD) is a strong predictor of adverse cardiac events in hypertrophic cardiomyopathy (HCM) patients. This finding aids in HCM risk stratification, making posterior descending artery (PD) assessment redundant.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Medical Diagnostics

Background:

  • Microvascular dysfunction is implicated in hypertrophic cardiomyopathy (HCM) progression.
  • The long-term prognostic significance of transthoracic Doppler echocardiography (TDE) derived coronary flow velocity reserve (CFVR) in HCM remains unclear.

Purpose of the Study:

  • To evaluate the long-term prognostic value of CFVR on clinical outcomes in patients with HCM.
  • To determine if CFVR assessment can aid in risk stratification for HCM patients.

Main Methods:

  • Prospective study of 150 HCM patients, assessing clinical, echocardiographic, and CFVR (LAD and PD) parameters.
  • Patients stratified by CFVR LAD values (Group 1: >2, Group 2: ≤2).
  • Primary outcome: composite of HCM-related death, heart failure hospitalization, sustained ventricular tachycardia, and ischemic stroke, with median follow-up of 88 months.

Main Results:

  • 41.3% of patients experienced adverse cardiac events during follow-up.
  • Group 2 (impaired CFVR LAD ≤2) had significantly higher adverse events (52.4%) compared to Group 1 (9.2%, P<0.001).
  • Impaired CFVR LAD (≤2) was identified as an independent predictor of adverse outcomes (HR 6.54, P<0.001), while CFVR PD was not significant.

Conclusions:

  • Reduced CFVR in the LAD artery is a robust, independent predictor of adverse clinical outcomes in HCM.
  • CFVR LAD assessment is crucial for risk stratification in HCM, rendering CFVR PD evaluation unnecessary when LAD data is available.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
46
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
121